Company intelligence / Profile preview

Primark

Ownership: Public · ABF
Development stage: Commercial

Overview

Primark Life Science is an active US-registered private distributor of medical devices, biotechnology products, and pharmaceutical quality control systems. The company focuses on supplying high-quality equipment and technical support to laboratories, clinical diagnostic centers, academic institutions, and healthcare providers in Sub-Saharan Africa. It plays a key role in supporting emerging biotech industries and raising healthcare standards through access to innovative technologies and quality controls for safe pharmaceuticals. There are no proprietary drug development programs or clinical results.

Industry: Non-Drug Biotech

Partnerships

Not specified by name; likely partners with manufacturers of medical devices/biotech/pharma QC systems for distribution purposes.

Financials

Market cap: $241.3M
Total revenue: $0
Enterprise value: $228.3M

Beyond the preview

Go deeper on Primark.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primark.

Explore the full profile